Category Archives: Limited Distribution Drugs

Orsini and PANTHERx Selected as Limited Distribution Pharmacies for Gilead Science’s Livdelzi

Orsini and PANTHERx Selected as Limited Distribution Pharmacies for Gilead Science’s Livdelzi for the treatment of primary biliary cholangitis (PBC)

Onco360 Selected as Pharmacy Partner for Servier Pharmaceutical’s VORANIGO and Genentech’s PiaSky

Onco360 Selected as Exclusive Pharmacy Partner for Servier Pharmaceutical’s VORANIGO and Genentech’s PiaSky

Accredo and CVS Caremark Selected by Merck as Limited Distribution Pharmacies for WINREVAIR

Accredo and CVS Caremark Selected by Merck as Limited Distribution Pharmacies for WINREVAIR

Biologics Selected as Exclusive Specialty Pharmacy Provider for CAMCEVI

Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Accord BioPharma, Inc. as an exclusive specialty pharmacy provider for CAMCEVI 

Cycle Pharmaceuticals Selects LeMed Specialty Pharmacy and Anovo as Exclusive Specialty Pharmacies

Cycle Pharmaceuticals Selects LeMed Specialty Pharmacy and Anovo as Exclusive Specialty Pharmacies for ORMALVI and Tiopronin

Specialty Pharmacy News Roundup: April 2024

Specialty Pharmacy News Roundup: April 2024. Stay up to date on industry and company trends with the Specialty Pharmacy Database

Walgreens Looking To Make a Significant Impact in Specialty Pharmacy Market

Walgreens plans to expand its specialty pharmacy services and invest in its capabilities as the company further grows its core pharmacy business to improve patient outcomes and provide greater value to payers and partners.

Onco360 Selected as Exclusive Specialty Pharmacy for Alexion Pharmaceutical’s Voydeya

Onco360 Selected as Exclusive Specialty Pharmacy to distribute Alexion Pharmaceutical’s Voydeya as a first class oral, Factor D inhibitor.